55 million
in US + EU5 with Severe Obesity & Diabetes
Need 30%+ Weight Loss
but
99% Refuse Surgery
92% Don't Reach 15% with Drugs
85% Quits Drugs
Anyway
That leaves ~46 million patients without a viable long-term solution
We Bridge the Gap, Unlocking Unmatched Weight Loss and Diabetes Reversal Potential
ForePass® is a fully reversible, perforation-free approach that overcomes the limitations of surgery and drugs—tailored for Class II & III patients (BMI ≥35) with comorbidities like type 2 diabetes, NASH, insulin resistance, or liver fibrosis
Keyron’s ForePass ® reproduces
Metabolic surgery without a single cut
ForePass®
is a fully endoscopic procedure designed to provide the same benefits of metabolic surgery, including a reversal of obesity, diabetes, NASH, and liver fibrosis.
What we do
How it works
The final ForePass ® GD device may differ in size and characteristics to that shown in these representations.
Created with Safety
& Efficacy in mind
ForePass ® is designed to reverse obesity, diabetes, and NASH because it replicates the mechanism of action of metabolic surgery. It aims to reproduce:
- The safety of gastric balloons
- The efficacy of gastric bypass surgery
A team of
World Class Experts
Our founders and team include some of the most renowned global experts in diabesity, endoscopy, metabolic surgery, and medical device engineering, and businesspeople with an outstanding track record in the obesity and medical device spaces, including large exits.
Severe Diabesity Treatment
We’re Setting the
We’re Setting the
New Standards
An engineering masterpiece
ForePass ® has been designed and produced by a team of world class US engineers with safety & efficacy on insulin resistance in mind
Impressive preclinical data
We demonstrated a reversal of diabetes & NASH in rodents and safety in swine
Globally renowned experts
Our team includes some of the brightest minds in diabetes and obesity research worldwide